When was Cell Matters founded?

Cell Matters was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Cell Matters located?

Cell Matters is headquartered in Liege, Belgium.

How many employees does Cell Matters have?

As of Dec 31, 2022, the latest employee count at Cell Matters is 6.

Is Cell Matters a funded company?

Cell Matters is a funded company, having raised a total of $872K across 2 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jan 23, 2018.

When was the latest funding round of Cell Matters?

Cell Matters' latest funding was a $***** Series A round on Jan 23, 2018, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In Belgium, the Life Sciences Platforms and Tools sector has seen $12M in funding in 2026 to date.

Where does Cell Matters rank among its competitors?

Cell Matters ranks 187th amongst 2725 active competitors, of which 92 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Huwel Life, which secured $5.64M in Sep, 2025.

Who are the top competitors of Cell Matters?

Cell Matters' top competitors include Abcam, Meridian Bioscience and IntegriChain. Among them, Huwel Life secured the most recent funding round in September, 2025.

Cell Matters - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Website: cell-matters.com
Social
Email ID: *****@cell-matters.com
Phone Number: +32 **********
Part Of

Key Metrics

Founded Year

2017

Location

Liege, Belgium

Stage

Series A

Total Funding

$872K in 2 rounds

Latest Funding Round

Series A, Jan 23, 2018, $*****

Investors

Paip investissements & 3 more

Ranked

187^th among 2725 active competitors

Employee Count

6 as on Dec 31, 2022

Similar Companies

Sino Biological & 341 more

View Cell Matters' full profile

Cell Matters is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
CRYOPORT BELGIUM CIN: 0676.713.669 , Belgium, Active	Jun 11, 2017	-	6 (As on Dec 31, 2022)	-
VITRICELL CIN: 0676713669 , Belgium, Active	Jun 11, 2017	-	-	-

Cell Matters has raised a total funding of $872K over 2 rounds. Its first funding round was on Jan 23, 2018. Its latest funding round was a Series A round on Jan 23, 2018 for $*****. 1 investor participated in its latest round. Cell Matters has 3 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Cell Matters:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 23, 2018	1375736	Series A	7930211	1156398	1425605	2982785
Jan 23, 2018	1861414	Conventional Debt	5194360	7577065	5251917	WBC Incubator

Access funding benchmarks and valuations. Sign up today!

View details of Cell Matters's funding rounds and investors

The founders of Cell Matters are Luc Grobet and Delphine Connan.

Here are the details of Cell Matters' key team members:

Luc Grobet: Co-Founder of Cell Matters and founder of 1 other company.
Delphine Connan: Co-Founder of Cell Matters.

View details of Cell Matters's Founder profiles and Board Members

Cell Matters' employee count trend

Cell Matters has 6 employees as of Dec 22. The total employee count is 50.0% more than what it was in Dec 21. Here is Cell Matters's employee count trend over the years:

Uncover Cell Matters' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cell Matters include Abcam, Meridian Bioscience and IntegriChain. Here is the list of Top 10 competitors of Cell Matters, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	65/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	63/100
5th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
6th	Stirling Ultracold 2009, Athens (United States), Acquired	Manufacturer of freezer for storage and preservation	$8.7M	Ohio Innovation Fund, Square 1 Bank & 5 others	62/100
7th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
8th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	61/100
9th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
10th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
187th	Cell Matters 2017, Liege (Belgium), Series A	CDMO focused on manufacturing of cell therapy products	$872K	Paip investissements, Noshaq & 2 others	35/100